Study guide

16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025)

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025)

Key Takeaways Explain This Topic AI

Each radiation phase is a distinct prescription recorded in its own items: primary treatment volume, draining lymph nodes, modality, planning technique, dose per fraction (cGy), number of fractions and total dose; Phase I must be coded, and Phases II and III may be blank.

Radiation modality codes include 02 photons, 03 protons, 04 electrons, 07–12 brachytherapy and 13–16 radioisotopes (for example, 13 for I-131); planning technique codes include 04 3-D conformal, 05 IMRT and 06–08 stereotactic.

Record the actual dose delivered, not the prescribed dose, rounded to whole cGy (1 rad = 1 cGy); total dose is 999998 when radioisotopes are given.

Chemotherapy [1390] is 00 none, 01 NOS, 02 single agent, 03 multiagent, 82 contraindicated, 85 died, 86 recommended but not given with no reason, 87 refused, 88 recommended but unknown if given, and 99 unknown.

Hematologic Transplant and Endocrine Procedures [3250] codes 11 autologous and 12 allogeneic transplant, 20 stem cell harvest and infusion, 30 endocrine surgery or radiation, and 40 a combination; Palliative Care [3270] records symptom-directed treatment in addition to the modality items.

Last updated: September 2026

  • Radiation
  • Phases

"A course of radiation is made up of one or more phases, and each phase reflects a distinct delivered prescription." STORE provides items for up to three phases . Number of Phases of Radiation Treatment [1532] records how many phases were actually given (01–98), so users can tell whether only part of the course was captured.

  • Item (Phase I / II / III) Content
  • Primary Treatment Volume [1504 / 1514 / 1524] The main target, for example breast, prostate or brain
  • Radiation to Draining Lymph Nodes [1505 / 1515 / 1525] Whether and which regional nodes were treated
  • Treatment Modality [1506 / 1516 / 1526] Beam, brachytherapy or radioisotope type
  • External Beam Planning Technique [1502 / 1512 / 1522] How the beams were planned
  • Dose per Fraction [1501 / 1511 / 1521] cGy per fraction
  • Number of Fractions [1503 / 1513 / 1523] Count of fractions
  • Total Dose [1507 / 1517 / 1527] Actual delivered phase dose in cGy

Phase I must be coded. Phases II and III may be blank if not given.

Modality codes [1506]

  • Code Modality
  • 00 No radiation
  • 01 External beam, NOS
  • 02 External beam, photons
  • 03 External beam, protons
  • 04 External beam, electrons
  • 05 / 06 Neutrons / carbon ions
  • 07–12 Brachytherapy : NOS, intracavitary LDR or HDR, interstitial LDR or HDR, electronic
  • 13–16 Radioisotopes : NOS (for example, I-131 ), radium-223, strontium-89, strontium-90
  • 98 Radiation given, modality unknown
  • 99 Unknown if radiation given; DCO

A radioiodine scan is diagnostic and is not recorded.

Planning technique codes [1502]

  • Code Technique
  • 01 External beam, NOS
  • 02 Low energy x-ray (below 1 MV; electronic brachytherapy, orthovoltage, superficial)
  • 03 2-D therapy (mostly palliative)
  • 04 Conformal or 3-D conformal
  • 05 Intensity modulated (IMRT, VMAT, IMPT)
  • 06 Stereotactic radiotherapy or radiosurgery, NOS (SBRT, SABR, SRS)
  • 07 / 08 Stereotactic, robotic (for example, CyberKnife) / Gamma Knife
  • 09 / 10 CT-guided / MR-guided online adaptive therapy
  • 88 Not applicable: treatment was not external beam (brachytherapy or radioisotopes)
  • 98 / 99 Other NOS / unknown
  • Dose rules

In general, dose per fraction × number of fractions = phase total dose .

Record the actual dose delivered, not the prescribed dose.

1 rad = 1 cGy. Round fractions of a cGy to the nearest whole number.

For radioisotopes (modality 13–16), dose per fraction is 99998 and total dose is 999998 .

For brachytherapy , code the actual cGy if it is available.

Other radiation items

Radiation Treatment Discontinued Early [1531]:

  • 00 none; 01 completed as prescribed;
  • 02 stopped for toxicity ; 03 contraindicated or progression ;

04 patient decision; 05 family decision; 06 patient died ; 07 reason not documented.

STORE example: cord compression after 5 of 10 fractions leads to surgery, with no return to radiation, giving 03 .

Reason for No Radiation [1430]:

  • 0 radiation given; 1 not part of the planned first course; 2 contraindicated;
  • 5 died before; 6 recommended, not given, no reason; 7 refused;

8 recommended, unknown if given; 9 unknown.

Radiation/Surgery Sequence [1380]:

0 no radiation and/or no surgery; 2 radiation before surgery; 3 radiation after surgery;

4 radiation both before and after surgery; 5 intraoperative radiation; 6 intraoperative radiation plus other radiation before or after;

7 surgery both before and after radiation; 9 sequence unknown.

"Surgery" here means primary site surgery, regional node surgery ( excluding code 1 , biopsy or aspiration) or other-site surgery.

Systemic therapy

Item Codes

Chemotherapy [1390] 00 none (not usually given, or the patient chose an option without it); 01 chemo NOS; 02 single agent ; 03 multiagent ; 82 contraindicated; 85 died before; 86 recommended, not given, no reason; 87 refused; 88 recommended, unknown if given; 99 unknown

  • Hormone Therapy [1400] 00 none; 01 hormone therapy given; 82, 85, 86, 87, 88, 99 as for chemotherapy
  • Immunotherapy [1410] 00 none; 01 immunotherapy given; 82, 85, 86, 87, 88, 99
  • Date Systemic Therapy Started [3230] The first date of any first-course systemic therapy

Coding points:

Use SEER*Rx to classify drugs.

Chemoembolization is coded 01–03 by the number of agents. With alcohol as the agent, it is Other Treatment.

Code 00 vs. 86/87: if the plan offered alternatives and the patient chose one without chemotherapy, the code is 00 , not refusal. 87 is used when recommended treatment was refused, including a blanket refusal of all treatment.

Code 88 means "recommended, not yet confirmed." The registry must follow these cases. If follow-up shows the patient never went to the specialist, change the code to 00 .

Hormone therapy:

Prednisone counts only when given with chemotherapy for the cancer.

TSH-suppressive thyroid hormone is 01.

Replacement hormones given only to restore normal function are not coded.

Hematologic Transplant and Endocrine Procedures [3250]

  • Code Meaning
  • 00 None
  • 10 Bone marrow transplant, type not specified
  • 11 Autologous bone marrow transplant
  • 12 Allogeneic bone marrow transplant
  • 20 Stem cell harvest and infusion ; umbilical cord stem cell transplant

30 Endocrine surgery and/or endocrine radiation , for example bilateral orchiectomy or oophorectomy for hormone control

  • 40 Combination of 30 with a transplant procedure
  • 82, 85, 86, 87, 88, 99 Reasons not given, and unknown
  • Other Treatment [1420]

Codes: 0 none; 1 other , for example phlebotomy, transfusion or aspirin for specific heme diseases per the Heme manual, or alcohol embolization; 2 experimental; 3 double-blind clinical trial; 6 unproven (given by nonmedical personnel); 7 refused; 8 recommended, unknown if given; 9 unknown.

Systemic/Surgery Sequence [1639]

Codes:

0: no systemic therapy and/or no surgery.

2: systemic therapy before surgery.

3: systemic therapy after surgery.

4: systemic therapy before and after surgery.

5: intraoperative systemic therapy.

6: intraoperative systemic therapy plus other systemic therapy before or after.

7: surgery both before and after systemic therapy.

9: sequence unknown.

STORE's example of code 2 is hormone therapy before a radical prostatectomy.

Palliative Care [3270]

  • Code Meaning
  • 0 No palliative care
  • 1 Surgery (including bypass) to relieve symptoms, with no attempt to diagnose, stage or treat the primary
  • 2 Radiation to relieve symptoms
  • 3 Systemic drugs to relieve symptoms
  • 4 Pain management only
  • 5 Any combination of 1, 2 or 3, without 4
  • 6 Any combination of 1, 2 or 3, with 4
  • 7 Palliative care given or referred, type unknown
  • 9 Unknown

Palliative treatment that is also cancer-directed is coded in both the modality item and Palliative Care. For example, palliative radiation to a bone metastasis goes in the radiation items and Palliative Care 2.

Worked examples

Breast: whole breast 4,005 cGy in 15 fractions with 3-D planning, then a tumor bed boost of 1,000 cGy in 4 fractions.

Number of Phases = 02 .

Phase I: modality 02, technique 04, dose per fraction 267, fractions 15, total 4005.

Phase II: dose per fraction 250, fractions 4, total 1000.

Radiation/Surgery Sequence 3 .

Thyroid: I-131, 150 mCi, after thyroidectomy. Modality 13 , planning technique 88 , total dose 999998 , Hormone Therapy 01 if TSH-suppressive levothyroxine is prescribed.

Myeloma: multiagent induction, then an autologous stem cell transplant. Code each drug in the item for its SEER*Rx category (for example, Chemotherapy 03 for a multiagent chemotherapy regimen), and code Hematologic Transplant and Endocrine Procedures 11 (autologous).

Pancreas: unresectable disease, with a biliary bypass for jaundice and a celiac block for pain. Palliative Care 6 (surgery + pain management), and the bypass does not count as primary site surgery.

Loading diagram... Radiation course structure